Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This framework agreement is for the provision of a High-Tech Homecare service for the purchasing, compounding, dispensing and delivery of injectable / infused anti-infective therapies, as well as the option of nurse administration initially for Patients of Member Trusts referred to (henceforth as the ‘Service’ to Participating Member Trusts. This Framework will also extend to the provision of Bedside Reconstitution if requested by the member Trusts
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Baxter Healthcare LTD - DUPLICATE | - | - | - |
| DUPLICATE - B. Braun Medical Ltd | - | - | - |
| Lloyds Pharmacy Clinical Homecare Limited | 02764914 | - | LOBBYIST 5654 & Company Limited (2 quarters) |
This procurement was divided into 4 lots, each awarded separately. 24 bids were received in total.
| Lot | Value | Status |
|---|---|---|
| Lot Lot 1 Treatment Packages 720 days (≈2 yrs) | - | cancelled |
| Lot Lot 2 Initial Product Range 720 days (≈2 yrs) | - | cancelled |
| Lot Lot 3 Delivery and Nursing 720 days (≈2 yrs) | - | cancelled |
| Lot Lot 4 Ancillary Packages 720 days (≈2 yrs) | - | cancelled |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £44,793,558 in 845 payments (over £25k) from Manchester University NHS Foundation Trust, NHS England, Maidstone and Tunbridge Wells NHS Trust, Plymouth Hospitals NHS Trust, University Hospitals Bristol and Weston NHS FT and 4 more public bodies (2014-04-30 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
This is a Provider Selection Regime (PSR) Intention to Award Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 14th October 2024. Representations can only be made by providers party to the framework agreement. This Contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.No Conflicts of Interest have been declared by any individual involved in this Tender and has been recorded on the Conflict of Interest register accordingly.The Tender panel was members of the East Midlands Pharmacy Collaborative Procurement Team and the Homecare Leads from the member Purchasing Authorities. Quality and Innovation 25%Improving access, reducing health inequalities and facilitating choice 15%Integration, collaboration and Service Sustainability 10%Social Value & Sustainability 10%Quality Total (Max 60%)60%Value Total (Max 10%) 10%Price 30%
Published by the buyer on this notice. Check the original notice — details change and are not updated here.